Published in J Virol on August 01, 1976
Cell-induced conformational change in poliovirus: externalization of the amino terminus of VP1 is responsible for liposome binding. J Virol (1990) 6.24
Neutralization of poliovirus by cell receptors expressed in insect cells. J Virol (1990) 2.77
Mutations in VP1 of poliovirus specifically affect both encapsidation and release of viral RNA. J Virol (1990) 2.25
Cholesterol is required for infection by Semliki Forest virus. J Cell Biol (1991) 2.24
Association of the polioviral RNA polymerase complex with phospholipid membranes. J Virol (1976) 2.14
The poliovirus 135S particle is infectious. J Virol (1996) 2.10
Mechanism of entry into the cytosol of poliovirus type 1: requirement for low pH. J Cell Biol (1984) 2.05
Formation of rhinovirus-soluble ICAM-1 complexes and conformational changes in the virion. J Virol (1993) 1.98
Uncoating of human rhinovirus serotype 2 from late endosomes. J Virol (1994) 1.96
Biological properties of poliovirus encapsulated in lipid vesicles: antibody resistance and infectivity in virus-resistant cells. Proc Natl Acad Sci U S A (1977) 1.57
Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J Virol (1998) 1.55
Picornaviruses. Curr Top Microbiol Immunol (2010) 1.53
Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol (1990) 1.41
Requirements for entry of poliovirus RNA into cells at low pH. EMBO J (1984) 1.41
Physical and metabolic requirements for early interaction of poliovirus and human rhinovirus with HeLa cells. J Virol (1976) 1.40
Insights into minor group rhinovirus uncoating: the X-ray structure of the HRV2 empty capsid. PLoS Pathog (2012) 1.25
Conformational changes, plasma membrane penetration, and infection by human rhinovirus type 2: role of receptors and low pH. J Virol (2003) 1.20
Thermostabilizing mutations in reovirus outer-capsid protein mu1 selected by heat inactivation of infectious subvirion particles. Virology (2007) 1.13
Mouse adaptation determinants of poliovirus type 1 enhance viral uncoating. J Virol (1996) 1.11
Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis. J Virol (2005) 1.11
A chimeric poliovirus/CD4 receptor confers susceptibility to poliovirus on mouse cells. J Virol (1992) 1.02
A positive-feedback mechanism promotes reovirus particle conversion to the intermediate associated with membrane penetration. Proc Natl Acad Sci U S A (2008) 0.96
Liposomal nanocontainers as models for viral infection: monitoring viral genomic RNA transfer through lipid membranes. J Virol (2011) 0.94
The poliovirus empty capsid specifically recognizes the poliovirus receptor and undergoes some, but not all, of the transitions associated with cell entry. J Virol (1998) 0.88
Viral uncoating is directional: exit of the genomic RNA in a common cold virus starts with the poly-(A) tail at the 3'-end. PLoS Pathog (2013) 0.88
Low pH-triggered beta-propeller switch of the low-density lipoprotein receptor assists rhinovirus infection. J Virol (2009) 0.86
Nonneutralizing human rhinovirus serotype 2-specific monoclonal antibody 2G2 attaches to the region that undergoes the most dramatic changes upon release of the viral RNA. J Virol (2006) 0.81
Human rhinovirus subviral a particle binds to lipid membranes over a twofold axis of icosahedral symmetry. J Virol (2013) 0.79
Stabilization of "A" particles of coxsackievirus B3 by a HeLa cell plasma membrane extract. J Virol (1979) 0.76
A rapid method of total lipid extraction and purification. Can J Biochem Physiol (1959) 173.74
CHROMATOGRAPHICALLY HOMOGENEOUS LECITHIN FROM EGG PHOSPHOLIPIDS. J Am Oil Chem Soc (1965) 6.66
Synthesis of lecithins by acylation of O-(sn-glycero-3-phosphoryl) choline with fatty acid anhydrides. Biochim Biophys Acta (1969) 3.53
Early alteration of poliovirus in infected cells and its specific inhibition. J Gen Virol (1975) 3.47
Early interaction of rhinoviruses with host cells. J Virol (1972) 3.16
Naturally occurring and artificially produced components of three rhinoviruses. Virology (1972) 2.84
A comparison of the virus-specific polypeptides of encephalomyocarditis virus, human rhinovirus-1A, and poliovirus. Virology (1973) 2.50
Association of the polioviral RNA polymerase complex with phospholipid membranes. J Virol (1976) 2.14
Characteristics of Sendai virus receptors in a model membrane. J Mol Biol (1974) 2.00
Letter to the editor: Fusion of Sendai viruses with model membranes. J Mol Biol (1974) 1.93
Interaction of Sindbis virus with liposomal model membranes. J Virol (1975) 1.85
Alteration of capsid proteins of coxsackievirus A13 by low ionic concentrations. J Virol (1975) 1.76
Comparison of in vitro and cell-mediated alteration of a human Rhinovirus and its inhibition by sodium dodecyl sulfate. J Virol (1973) 1.59
Fractionation of biologically active and inactive populations of human rhinovirus type 2. Virology (1975) 1.39
'Phagocytosis' of sendai virus by model membranes. J Gen Virol (1975) 1.27
Antigenic determinants of infective and inactivated human rhinovirus type 2. J Virol (1973) 1.22
Lateral phase separation in phospholipid membranes. Biochemistry (1973) 6.56
Virus-receptor interaction in an adenovirus system. J Virol (1968) 4.69
Early events of virus-cell interaction in an adenovirus system. J Virol (1969) 3.68
Early alteration of poliovirus in infected cells and its specific inhibition. J Gen Virol (1975) 3.47
Unrelated animal viruses share receptors. Nature (1976) 3.24
Early interaction of rhinoviruses with host cells. J Virol (1972) 3.16
Priming: a nonantiviral function of interferon. J Virol (1971) 2.95
Naturally occurring and artificially produced components of three rhinoviruses. Virology (1972) 2.84
A monoclonal antibody specific for the cellular receptor for the group B coxsackieviruses. J Virol (1988) 2.69
Structural proteins of adenoviruses. IV. Sequential degradation of the adenovirus type 2 virion. Virology (1970) 2.65
Lateral phase separations in binary mixtures of cholesterol and phospholipids. Biochem Biophys Res Commun (1973) 2.62
Early interaction between animal viruses and cells. Monogr Virol (1974) 2.43
Association of the polioviral RNA polymerase complex with phospholipid membranes. J Virol (1976) 2.14
Investigation of the structure of polio- and human rhinovirions through the use of selective chemical reactivity. Virology (1976) 1.91
Comparison of in vitro and cell-mediated alteration of a human Rhinovirus and its inhibition by sodium dodecyl sulfate. J Virol (1973) 1.59
Zonal electrophoresis and isoelectric focusing of proteins and virus particles in density gradients of small volume. Anal Biochem (1974) 1.53
Interactions of components of human rhinovirus type 2 with Hela cells. Virology (1973) 1.53
Physical and metabolic requirements for early interaction of poliovirus and human rhinovirus with HeLa cells. J Virol (1976) 1.40
Fractionation of biologically active and inactive populations of human rhinovirus type 2. Virology (1975) 1.39
Adsorption of rhizobia to cereal roots. Biochem Biophys Res Commun (1978) 1.33
Antigenic determinants of infective and inactivated human rhinovirus type 2. J Virol (1973) 1.22
Replication of rhinoviruses. Arch Virol (1976) 1.20
Lateral phase separations in membranes. J Supramol Struct (1973) 1.16
Distinguishing characteristics of the interferon responses of primary and continuous mouse cell cultures. J Gen Virol (1971) 1.15
Lack of close relationship between three strains of human rhinoviruses as determined by their RNA sequences. J Virol (1973) 1.05
Three high molecular weight protease inhibitors of rat plasma. Isolation, characterization, and acute phase changes. J Biol Chem (1987) 1.04
Sequential steps in attachment of human rhinovirus type 2 to HeLa cells. J Gen Virol (1974) 0.96
The effects of concanavalin A on the early events of infection by rhinovirus type 2 and poliovirus type 2. J Gen Virol (1975) 0.95
The effect of priming with interferon on interferon production by two lines of L cells. J Gen Virol (1972) 0.89
Rotational correlation time of spin-labeled alpha-chymotrypsin. Biochem Biophys Res Commun (1972) 0.87
Improved conversion of fumarate to succinate by Escherichia coli strains amplified for fumarate reductase. Appl Environ Microbiol (1983) 0.87
Two-dimensional gel electrophoresis method for investigation of human plasma proteins: detection of subtle changes during filtration leukapheresis. Clin Chem (1982) 0.84
Three high molecular weight protease inhibitors of rat plasma. Reactions with trypsin. J Biol Chem (1987) 0.84
Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors. J Med Chem (1995) 0.81
Fate of adenovirus during the early phase of infection. J Gen Microbiol (1969) 0.75
Classification of malnutrition by statistical analysis of quantitative two-dimensional gel electrophoresis of plasma proteins. Comput Biomed Res (1986) 0.75
Studies on the proteins of adenovirus type 2. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 0.75
Whole blood and plasma concentrations of 4-hydroxy-2-nonenal in Watanabe heritable hyperlipidemic versus New Zealand White rabbits. Biochem Biophys Res Commun (1994) 0.75